Literature DB >> 21384108

A novel WT1 gene mutation in a patient with Wilms' tumor and 46, XY gonadal dysgenesis.

Dong-Gi Lee1, Deok Hyun Han, Kwan Hyun Park, Minki Baek.   

Abstract

Denys-Drash syndrome (DDS) is a rare genetic disorder featuring the triad of Wilms' tumor, early-onset renal failure, and 46, XY disorder of sex development. DDS is usually caused by heterozygous missense mutations in the zinc-finger region of the WT1 gene. The most frequent constitutional WT1 mutations in DDS patients are missense mutations in exons 8 and 9. We present a new case of variable DDS in a child who was found to have a novel heterozygous missense mutation in exon 7 (c.905G>T) and a splicing mutation in exon 6 (IVS6-1G>T).

Entities:  

Mesh:

Year:  2011        PMID: 21384108     DOI: 10.1007/s00431-011-1439-0

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  16 in total

1.  Genetic analysis of two female patients with incomplete Denys-Drash syndrome.

Authors:  S Ohta; T Ozawa; H Shiraga; H Fuse
Journal:  Endocr J       Date:  2000-12       Impact factor: 2.349

2.  A novel WT1 missense mutation presenting with Denys-Drash syndrome and cortical atrophy.

Authors:  Valérie Schumacher; Julia Thumfart; Matthias Drechsler; Maximillian Essayie; Brigitte Royer-Pokora; Uwe Querfeld; Dominik Müller
Journal:  Nephrol Dial Transplant       Date:  2005-11-22       Impact factor: 5.992

Review 3.  Human male sex determination and sexual differentiation: pathways, molecular interactions and genetic disorders.

Authors:  Laimutis Kucinskas; Walter Just
Journal:  Medicina (Kaunas)       Date:  2005       Impact factor: 2.430

Review 4.  46,XY disorders of sex development (DSD).

Authors:  Berenice Bilharinho Mendonca; Sorahia Domenice; Ivo J P Arnhold; Elaine M F Costa
Journal:  Clin Endocrinol (Oxf)       Date:  2009-02       Impact factor: 3.478

5.  Germline Wilms tumor suppressor gene (WT1) mutation leading to isolated genital malformation without Wilms tumor or nephropathy.

Authors:  B Köhler; V Schumacher; D l'Allemand; B Royer-Pokora; A Grüters
Journal:  J Pediatr       Date:  2001-03       Impact factor: 4.406

Review 6.  WT1 (Wilms' tumor gene 1): biology and cancer immunotherapy.

Authors:  Haruo Sugiyama
Journal:  Jpn J Clin Oncol       Date:  2010-04-15       Impact factor: 3.019

Review 7.  A WT1 exon 1 mutation in a child diagnosed with Denys-Drash syndrome.

Authors:  Suzanne Little; Sandra Hanks; Linda King-Underwood; Sue Picton; Catherine Cullinane; Elizabeth Rapley; Nazneen Rahman; Kathy Pritchard-Jones
Journal:  Pediatr Nephrol       Date:  2004-10-21       Impact factor: 3.714

8.  A novel mutation of WT1 exon 9 in a patient with Denys-Drash syndrome and pyloric stenosis.

Authors:  Min Hu; Jonathon Craig; Neville Howard; Alex Kan; Jeffrey Chaitow; Dianne Little; Stephen I Alexander
Journal:  Pediatr Nephrol       Date:  2004-07-28       Impact factor: 3.714

9.  A novel Wilms' tumor 1 gene mutation in a child with severe renal dysfunction and persistent renal blastema.

Authors:  Nicole Wagner; Kay-Dietrich Wagner; Mickael Afanetti; Fabien Nevo; Corinne Antignac; Jean-Francois Michiels; Andreas Schedl; Etienne Berard
Journal:  Pediatr Nephrol       Date:  2008-05-31       Impact factor: 3.714

10.  YAC complementation shows a requirement for Wt1 in the development of epicardium, adrenal gland and throughout nephrogenesis.

Authors:  A W Moore; L McInnes; J Kreidberg; N D Hastie; A Schedl
Journal:  Development       Date:  1999-05       Impact factor: 6.868

View more
  2 in total

Review 1.  Mammalian sex determination—insights from humans and mice.

Authors:  Stefanie Eggers; Andrew Sinclair
Journal:  Chromosome Res       Date:  2012-01       Impact factor: 5.239

2.  Long-term kidney function in children with Wilms tumour and constitutional WT1 pathogenic variant.

Authors:  Maria Pia Falcone; Kathryn Pritchard-Jones; Jesper Brok; William Mifsud; Richard D Williams; Kayo Nakata; Suzanne Tugnait; Reem Al-Saadi; Lucy Side; John Anderson; Catriona Duncan; Stephen D Marks; Detlef Bockenhauer; Tanzina Chowdhury
Journal:  Pediatr Nephrol       Date:  2021-10-04       Impact factor: 3.651

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.